Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2026-02-20 @ 1:43 PM
Study NCT ID:
NCT02164461
Status:
COMPLETED
Last Update Posted:
2024-05-20
First Post:
2014-06-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Sponsor:
Advaxis, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Lm-LLO-E7-1401 (ADXS001-07)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None